HYUGA PRIMARY CARE Co.,Ltd. (7133) AI Stock Analysis

HYUGA PRIMARY CARE Co.,Ltd.

(TSE/TYO:7133)

Select Model

Rating:59Neutral

Price Target:JPY 1,715.00▼(-18.57% Downside)

Action:reiterated

Date:09/29/26

The stock scores 59, reflecting a balance of strong technical momentum and solid revenue growth against financial headwinds. The most significant positive factor is the bullish technical trend, with the price significantly above all major moving averages and healthy momentum indicators. This is tempered by weakening financial fundamentals, notably compressed margins and minimal free cash flow generation due to elevated capital expenditures. Valuation is neutral, with a P/E near 19 offering fair value for the growth profile.

Positive Factors

Consistent Revenue GrowthSustained revenue expansion indicates continued demand for the company’s pharmacy and primary-care support services. Growth at this pace can broaden the operating base, improve scale economics, and provide resources to reinvest in patient support and service capacity over the next several quarters.

Negative Factors

Margin CompressionThe sharp decline in gross and net margins shows that higher sales are not currently translating into proportional profit growth. If cost pressure or unfavorable mix persists, earnings quality could remain weaker and reduce the funds available for expansion, service investment, or balance-sheet improvement.

HYUGA PRIMARY CARE Co.,Ltd. (7133) vs. iShares MSCI Japan ETF (EWJ)

Market Cap: JPY 15.02B
Dividend Yield: 0.95%
Average Volume (3M): 29.35K
Price to Earnings (P/E): 24.4
Beta (1Y): 0.12
Revenue Growth: 22.80%
EPS Growth: -10.77%
Country: Japan
Employees: 882
Sector: General
Sector Strength: 55
Industry: Medical - Care Facilities

HYUGA PRIMARY CARE Co.,Ltd. Business Overview & Revenue Model

Company Description

HYUGA PRIMARY CARE Co.,Ltd., established in 2007 and based in Kasuga, Japan, specializes in delivering a variety of primary care services, encompassing home-visit pharmacies, nursing support, and personalized care planning. The company extends its ex...

How the Company Makes Money

The company primarily generates revenue through dispensing-pharmacy operations, where it earns fees associated with filling prescriptions issued by medical institutions and receives payment for providing medication guidance and related pharmacy servi...

HYUGA PRIMARY CARE Co.,Ltd. Financial Statement Overview

Summary

Financial performance is moderate. Strong 20% revenue growth is offset by margin compression (gross margin fell to 18.7%, net margin to 4.2%) and weak free cash flow of ¥36M due to high capex. The balance sheet shows improved but still elevated leverage (D/E 1.18).

Income Statement

58Neutral

Balance Sheet

55Neutral

Cash Flow

40Negative

Financial statement breakdown
Breakdown	TTM	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Income Statement
Total Revenue	12.68B	11.98B	9.98B	8.29B	6.66B	5.78B
Gross Profit	2.38B	2.25B	2.41B	1.88B	1.56B	1.24B
EBITDA	1.37B	1.18B	1.31B	854.38M	627.27M	568.69M
Net Income	614.95M	501.88M	719.03M	441.03M	382.88M	328.45M
Balance Sheet
Total Assets	8.67B	8.29B	7.05B	6.35B	2.92B	2.54B
Cash, Cash Equivalents and Short-Term Investments	1.24B	1.02B	565.93M	688.01M	567.69M	719.56M
Total Debt	2.86B	3.22B	2.65B	2.80B	251.54M	330.21M
Total Liabilities	5.90B	5.56B	4.68B	4.71B	1.44B	1.46B
Stockholders Equity	2.77B	2.73B	2.37B	1.64B	1.48B	1.07B
Cash Flow
Free Cash Flow	0	35.71M	485.51M	473.20M	102.59M	228.92M
Operating Cash Flow	0	492.94M	771.32M	706.64M	342.25M	484.60M
Investing Cash Flow	0	-319.13M	-473.98M	-1.13B	-383.39M	-320.25M
Financing Cash Flow	0	281.88M	-419.43M	538.78M	-110.73M	16.93M

HYUGA PRIMARY CARE Co.,Ltd. Technical Analysis

Technical Analysis SentimentPositive

Last Price2106.00

Price Trends

50DMA1699.24Positive

100DMA1425.84Positive

200DMA1253.00Positive

Market Momentum

MACD109.67Positive

RSI95.10Negative

STOCH66.67Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7133, the sentiment is Positive. The current price of 2106.00 is above the 20-day moving average (MA) of 2105.45, above the 50-day MA of 1699.24, and above the 200-day MA of 1253.00, indicating a bullish trend. The MACD of 109.67 indicates Positive momentum. The RSI at 95.10 is Negative, neither overbought nor oversold. The STOCH value of 66.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7133.

HYUGA PRIMARY CARE Co.,Ltd. Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

JP:7133 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
JP:7071	64Neutral	JPY 38.05B	11.89	―	1.04%	6.17%	-33.01%
JP:7133	59Neutral	JPY 15.34B	24.42	―	0.95%	22.80%	-10.77%
JP:2425	56Neutral	JPY 2.50B	29.54	―	3.35%	-5.72%	-73.78%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
JP:2373	52Neutral	JPY 5.26B	17.98	―	4.45%	4.76%	-52.55%
JP:7061	46Neutral	JPY 3.90B	11.55	―	5.54%	14.91%	-39.00%

* General Sector Average

Performance Comparison

JP:7133 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
JP:7133	HYUGA PRIMARY CARE Co.,Ltd.	2106.00	874.19	70.97%
JP:2373	Care Twentyone Corporation	382.00	-60.66	-13.70%
JP:2425	Care Service Co., Ltd.	657.00	-121.64	-15.62%
JP:7061	Japan Hospice Holdings Inc.	451.00	-872.95	-65.94%
JP:7071	Amvis Holdings.Inc.	383.00	-141.65	-27.00%

HYUGA PRIMARY CARE Co.,Ltd. Corporate Events

HYUGA PRIMARY CARE Unveils Q1 FY2027 Results and Outlook

Aug 27, 2026

HYUGA PRIMARY CARE Co., Ltd. released its financial results for the first quarter of the fiscal year ending March 2027, outlining performance and trends under its TSE Growth Market listing. The disclosure highlights how the quarter’s results fi...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 29, 2026

HYUGA PRIMARY CARE Co.,Ltd. AI Stock Analysis